Halozyme Therapeutics HALO announced that it has entered into a definitive agreement with Antares Pharma ATRS to acquire the latter for approximately $960 million. The acquisition will add Antares’ ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Halozyme Therapeutics Inc is bolstering its drug delivery platform with a $960 million all-cash deal for specialty ...
Transaction Expected to be Immediately Accretive to Revenue and Non-GAAP Earnings in 2022 with Multiple Drivers to Accelerate Financial Growth Through 2027 and Beyond Augments Drug Delivery Business ...
Halozyme Therapeutics Inc., headquartered in San Diego, and Antares Pharma Inc. of Ewing Township announced April 13 that they entered into a definitive agreement for Halozyme to acquire Antares for ...
Pfizer has tapped Antares Pharma for the development of a self-administered combination drug-device rescue pen for an undisclosed medicine, shortly after investing $465 million in a new sterile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results